{rfName}
Va

Indexed in

Altmetrics

Analysis of institutional authors

Bartra, JAuthorValero, AAuthorMullol, JAuthor

Share

February 21, 2025
Publications
>
Article
No

Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort Study

Publicated to: RHINOLOGY. 48 (2): 201-205 - 2010-06-01 48(2), DOI: 10.4193/Rhin09.099

Authors:

del Cuvillo, Alfonso; Montoro, Javier; Bartra, Joan; Valero, Antonio; Ferrer, Marta; Jauregui, Ignacio; Davila, Ignacio; Sastre, Joaquin; Mullol, Joaquim
[+]

Affiliations

- Author
Clin Dr Lobaton, ENT Dept, E-11008 Cadiz, Spain - Author
Clin Univ, Dept Alergia, Pamplona, Spain - Author
Enfermedades Respiratorias, Ctr Invest Biomed & Red CIBERES, Vitoria, Spain - Author
Fdn Jimenez Diaz, Serv Alergia, E-28040 Madrid, Spain - Author
Hosp Basurto, Serv Alergol, Bilbao, Spain - Author
Hosp Clin Barcelona, Serv Pneumol & Allergia Respiratoria, Barcelona, Spain - Author
Hosp Clin IDIBAPS, Serv Otorinolaringol, Unitat Rinol & Clin Olfacte, Barcelona, Spain - Author
Hosp Clin Salamanca, Serv Inmunoalergia, Salamanca, Spain - Author
Hosp La Plana, Unidad Alergia, Villarreal, Castellon, Spain - Author
See more

Abstract

Introduction: Allergic rhinitis (AR) is an increasingly prevalent worldwide disease, which has an important impact on quality of life and generates high social and health care costs. The ARIA classification, that considers both the duration and severity of AR, seems more appropriate than previous classifications of AR, but few studies exist on the validation of the severity criteria proposed by the ARIA classification. Objectives: To assess the ARIA duration and severity classification of AR in a large sample population of patients, by investigating whether different degrees of severity correlate with differences in symptom score, quality of life or the patient's self evaluation of impairment. This study also assesses the relationship between AR severity and comorbidities. Material and Methods: An observational, cross-sectional, multicentre study conducted in Spain. AR was classified based on the ARIA criteria, and compared to the classical classification based on allergen exposure. Rhinitis was evaluated by the Total 4-Symptom Score (T4SS) scale, quality of life was measured using the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ), and disease severity through a Visual Analogue Scale (VAS, 0-100 mm). Comorbidities were evaluated based both on the duration and severity of the symptoms of rhinitis. Results: AR patients, (n = 3,529; mean age 37.5 +/- 13.4 years.; 52.3% women) were included in the study. AR patients were classified as intermittent (51.5%) and persistent (48.5%) based on the ARIA classification, and as seasonal (61.2%), perennial (35.1%), and occupational (3.7%) based on the allergen exposure classification. Significantly higher T4SS, RQLQ and VAS scores were obtained in moderate/severe compared to mild AR. The incidence of asthma was significantly higher in patients with persistent and moderate/severe AR compared to intermittent and mild AR. Asthma was the only comorbidity to reach statistical significance. Conclusion: ARIA classification of severity reflects two different statuses of AR in terms of symptoms and quality of life. Asthma was the only concomitant pathology in which incidence was related to ARIA categories in terms of duration or severity.
[+]

Keywords

Allergic rhinitisAriaAsthmaBacteremiaCloneEmergenceEpidemiologEpidemiologyGuidelinesImpactIntermittentLifePrevalencePrimary-careQuality of lifeRhinoconjunctivitisRiskSeveritySkinSpainTrialUpdatUpdate

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal RHINOLOGY due to its progression and the good impact it has achieved in recent years, according to the agency Scopus (SJR), it has become a reference in its field. In the year of publication of the work, 2010, it was in position , thus managing to position itself as a Q1 (Primer Cuartil), in the category Otorhinolaryngology.

Independientemente del impacto esperado determinado por el canal de difusión, es importante destacar el impacto real observado de la propia aportación.

Según las diferentes agencias de indexación, el número de citas acumuladas por esta publicación hasta la fecha 2026-04-05:

  • WoS: 43
  • Scopus: 38
  • Europe PMC: 27
[+]

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2026-04-05:

  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 36 (PlumX).
[+]

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (Mullol i Miret, Joaquim).

[+]

Awards linked to the item

This study was partly funded by an educational grant from UCB Pharma in Spain.
[+]